Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study.
about
Deficiency of the LIM-only protein FHL2 reduces intestinal tumorigenesis in Apc mutant mice.FHL2 expression in peritumoural fibroblasts correlates with lymphatic metastasis in sporadic but not in HNPCC-associated colon cancer.FHL2 interacts with CALM and is highly expressed in acute erythroid leukemia.Epithelial expression of FHL2 is negatively associated with metastasis-free and overall survival in colorectal cancerMammalian Actin-binding Protein-1/Hip-55 Interacts with FHL2 and Negatively Regulates Cell InvasionThe four and a half LIM domains 2 (FHL2) regulates ovarian granulosa cell tumor progression via controlling AKT1 transcription.The FHL2 regulation in the transcriptional circuitry of human cancers.EpCAM regulates cell cycle progression via control of cyclin D1 expression.FHL2 interacts with iASPP and impacts the biological functions of leukemia cells.Krüppel-like factor 8 induces epithelial-to-mesenchymal transition and promotes invasion of pancreatic cancer cells through transcriptional activation of four and a half LIM-only protein 2Interaction of TACC proteins with the FHL family: implications for ERK signaling.Plumbagin exhibits an anti-proliferative effect in human osteosarcoma cells by downregulating FHL2 and interfering with Wnt/β-catenin signalling.Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD).FHL2 interacts with EGFR to promote glioblastoma growth.BAG3 Overexpression and Cytoprotective Autophagy Mediate Apoptosis Resistance in Chemoresistant Breast Cancer Cells.
P2860
Q33815903-14CC2A88-FC7F-464C-99E6-0166E7503891Q34206722-C2F2ECB9-8DC2-4C55-9A1D-6FBB5DAFD74DQ35668394-E28FE247-0188-46FF-85DD-73794BC18E62Q37003274-B3EA4575-0C9F-433F-A7C9-9C0D08C1DD68Q37065685-A3C94633-8694-4A62-A258-0BA59F535642Q37151504-A26CDF3A-650C-433D-AF20-92A13C97D201Q38554494-51BDBC87-D799-4615-96BB-A9E1DDFD6F6FQ39385183-BFC0154C-0D07-447E-AAD5-BCE34E19300BQ41092432-06C3E6ED-F422-4C79-A417-4C9DEAF8E1EAQ41297598-67DAFCFD-5AAE-4721-8C1B-AC0FBB5C1F23Q41959511-C8D472CC-E2E8-48EB-8F16-22213ECD946CQ42051646-E2C04CB4-A739-41DD-93BD-58E7B4B0D279Q46142296-BCA74A9B-FF33-48EE-B199-E9F123E01AC8Q47871595-7D5ED421-9399-4754-82C2-72D459F79664Q49806879-822F9E3F-0788-408D-AF53-3726C3E5528B
P2860
Expression of the transcriptional coregulator FHL2 in human breast cancer: a clinicopathologic study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression of the transcriptio ...... er: a clinicopathologic study.
@ast
Expression of the transcriptio ...... er: a clinicopathologic study.
@en
Expression of the transcriptio ...... er: a clinicopathologic study.
@nl
type
label
Expression of the transcriptio ...... er: a clinicopathologic study.
@ast
Expression of the transcriptio ...... er: a clinicopathologic study.
@en
Expression of the transcriptio ...... er: a clinicopathologic study.
@nl
prefLabel
Expression of the transcriptio ...... er: a clinicopathologic study.
@ast
Expression of the transcriptio ...... er: a clinicopathologic study.
@en
Expression of the transcriptio ...... er: a clinicopathologic study.
@nl
P2093
P2860
P1476
Expression of the transcriptio ...... er: a clinicopathologic study.
@en
P2093
Annette Hasenburg
Axel zur Hausen
Boris Gabriel
Dagmar-C Fischer
Judith M Müller
M Orlowska-Volk
Roland Schüle
P2860
P356
10.1016/J.JSGI.2005.10.001
P577
2006-01-01T00:00:00Z